How do I buy Spero Therapeutics (SPRO) stock?

You can purchase shares of Spero Therapeutics (NASDAQ:SPRO) through any online brokerage.View our list of the best stock brokerages

Who are Spero Therapeutics (SPRO) competitors?

Other companies in Spero Therapeutics’s space includes: Molecular Partners AG (NASDAQ:MOLN), Connect Biopharma Holdings Ltd (NASDAQ:CNTB), Elicio Therapeutics Inc (NASDAQ:ELTX), Fate Therapeutics Inc (NASDAQ:FATE) and Whitehawk Therapeutics Inc (NASDAQ:WHWK).

What is the forecast, or price target, for Spero Therapeutics (SPRO) stock?

Spero Therapeutics has a consensus price target of $5.00.

What is the current price for Spero Therapeutics (SPRO)?

The stock price for Spero Therapeutics (NASDAQ: SPRO) is $2.45 last updated January 23, 2026 at 5:48 PM EST.

Does Spero Therapeutics (SPRO) pay a dividend?

There are no upcoming dividends for Spero Therapeutics.

When is Spero Therapeutics (NASDAQ:SPRO) reporting earnings?

Spero Therapeutics does not have any upcoming earnings scheduled.

Is Spero Therapeutics (SPRO) going to split?

There is no upcoming split for Spero Therapeutics.

What sector and industry does Spero Therapeutics (SPRO) operate in?

Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Spero Therapeutics (SPRO) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, teb...

Comments